An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.

Authors :: Oh, J.
Tyldesley, S.
Pai, H.H.
McKenzie, M.R.
Halperin, R.M.
Duncan, G.G.
Morton, G.
Keyes, M.
Hamm, J.
Morris, W.J.
Source :: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pS62-S62. 1p.
Publication Year :: 2020

Subjects :: *PROSTATE cancer
*SURVIVAL analysis (Biometry)
*RADIOISOTOPE brachytherapy

Full Text Access

Tools